Author:
Delavari Behdad,Mamashli Fatemeh,Bigdeli Bahareh,Poursoleiman Atefeh,Karami Leila,Zolmajd-Haghighi Zahra,Ghasemi Atiyeh,Samaei-Daryan Samaneh,Hosseini Morteza,Haertlé Thomas,Muronetz Vladimir I.,Halskau Øyvind,Moosavi-Movahedi Ali Akbar,Goliaei Bahram,Rezayan Ali Hossein,Saboury Ali Akbar
Publisher
Springer Science and Business Media LLC
Reference74 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87–108 (2015).
2. Chowdhury, M. R., Schumann, C., Bhakta-Guha, D. & Guha, G. Cancer nanotheranostics: Strategies, promises and impediments. Biomedicine & Pharmacotherapy 84, 291–304 (2016).
3. Vong, L. B. & Nagasaki, Y. Combination treatment of murine colon cancer with doxorubicin and redox nanoparticles. Molecular pharmaceutics 13, 449–455 (2016).
4. Burke, P. J. & Koch, T. H. Design, synthesis, and biological evaluation of doxorubicin− formaldehyde conjugates targeted to breast cancer cells. Journal of medicinal chemistry 47, 1193–1206 (2004).
5. Prados, J. et al. Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 12, 1058–1070 (2012).
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献